10 of 10 routes returned a live 40210 CURATED ROUTESclinicalintelpulse.vercel.app
clinicalintelpulse
Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.
10
resources
2
data sources
2
network identifiers
55
registry calls / 30d
RESOURCE SAMPLE · 10 OF 10
search all →GET
https://clinicalintelpulse.vercel.app/api/clinical/pipeline-scan
https://clinicalintelpulse.vercel.app/api/clinical/pipeline-scan
402 quote
GET
https://clinicalintelpulse.vercel.app/api/clinical/global-trials
https://clinicalintelpulse.vercel.app/api/clinical/global-trials
402 quote
GET
https://clinicalintelpulse.vercel.app/api/clinical/patient-finder
https://clinicalintelpulse.vercel.app/api/clinical/patient-finder
402 quote
GET
https://clinicalintelpulse.vercel.app/api/clinical/approval-outlook
https://clinicalintelpulse.vercel.app/api/clinical/approval-outlook
402 quote
GET
https://clinicalintelpulse.vercel.app/api/clinical/disease-landscape
https://clinicalintelpulse.vercel.app/api/clinical/disease-landscape
402 quote
GET
https://clinicalintelpulse.vercel.app/api/clinical/failure-analysis
https://clinicalintelpulse.vercel.app/api/clinical/failure-analysis
402 quote
GET
https://clinicalintelpulse.vercel.app/api/clinical/mechanism-map
https://clinicalintelpulse.vercel.app/api/clinical/mechanism-map
402 quote
GET
https://clinicalintelpulse.vercel.app/api/clinical/sponsor-intel
https://clinicalintelpulse.vercel.app/api/clinical/sponsor-intel
402 quote
GET
https://clinicalintelpulse.vercel.app/api/clinical/trial-brief
https://clinicalintelpulse.vercel.app/api/clinical/trial-brief
402 quote
GET
https://clinicalintelpulse.vercel.app/api/clinical/deal-signal
https://clinicalintelpulse.vercel.app/api/clinical/deal-signal
402 quote